Sylvie Meillerais started her career in research, in academia and industry, and moved to regulatory policy through positions in Brussels pharmaceutical trade associations, including EFPIA. She then joined MSD as Director Global Regulatory Policy in June 2015; in her current role, her expertise and knowledge of the European pharmaceutical environment serves to drive regulatory policy activities in the areas of CMC and Quality in the EU and globally. She is an active member of the EFPIA Manufacturing and Quality Experts Group and of the Middle East network, where she leads the Life Cycle Management efforts. She is further engaged in IFPMA CMC & Quality policy activities.

Sylvie is a French national and graduated from the University of Bordeaux II with a Maîtrise in Biochemistry and Microbiology in 1993, completed by a Diploma from the University of Kent at Canterbury in the UK (Erasmus programme).

Sylvie can be followed on <a href=”https://www.linkedin.com/” tabindex=”-1″>linkedin</a>